A warning was included in section 4.4 with a cross reference to section 4.9 stating that central nervous system stimulation with convulsions or cardiovascular collapse with accompanying hypotension may be produced by sympathomimetic amines and that these effects may be more likely to occur in children, the elderly, or in cases of overdose.